Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics (OTLK) Q1 2025 Earnings
OTLK
14
Feb
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.55
-1.29
-1.02
-0.76
Details
Expected EPS
-0.76
Actual EPS
-0.89
Surprise EPS
-0.13
Surprise Percent
+17.11%
Description
Outlook Therapeutics (OTLK) has reported earnings of -0.89 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login